Clinical Trials Directory

Trials / Completed

CompletedNCT02026830

The Microbiologic Profile of Diabetic Foot Infections in Turkey - TURK-DAY

The Microbiologic Profile of Diabetic Foot Infections in Turkey (TURK-DAY): Prospective Multicenter Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
447 (actual)
Sponsor
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Accepted

Summary

To determine the causative microorganisms and their antibiotic sensitivity patterns in diabetic patients with a foot infection in Turkey.

Detailed description

Recent studies have demonstrated substantial variation in the etiology of DFIs (Diabetic Foot Infections) in different regions of the world . In contrast to Western countries, studies from Asia and Africa have demonstrated that aerobic gram-negative organisms, particularly Pseudomonas aeruginosa, are far more common . The majority of current guidelines for the management of DFIs have been prepared in Western countries . Based on the results of more recent studies from the Asian continent, however, empiric antibiotic therapy for DFIs may need to be directed at organisms with substantially different antibiotic susceptibility patterns than those recommended in current guidelines. Thus, suggested antibiotic regimens for DFIs should be optimized for local clinical practice. The aim of the current trial is to provide an up-to-date view of the causative microorganisms and their antibiotic sensitivity patterns in diabetic patients with a foot infection in Turkey.

Conditions

Timeline

Start date
2014-01-01
Primary completion
2014-04-01
Completion
2014-07-01
First posted
2014-01-03
Last updated
2015-03-11

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02026830. Inclusion in this directory is not an endorsement.